107 related articles for article (PubMed ID: 17709273)
21. Essential role of TM V and VI for binding the C-terminal sequences of Des-Arg-kinins.
Santos EL; de Picoli Souza K; Cibrián-Uhalte E; Oliveira SM; Bader M; Costa-Neto CM; Oliveira L; Pesquero JB
Int Immunopharmacol; 2008 Feb; 8(2):282-8. PubMed ID: 18182241
[TBL] [Abstract][Full Text] [Related]
22. Rat brain capillary thrombomodulin: structure and function.
Wang L; Tran ND; Schreiber SS; Fisher M; Zlokovic BV
Thromb Res; 1998 Dec; 92(5):213-9. PubMed ID: 9851812
[TBL] [Abstract][Full Text] [Related]
23. Thrombomodulin-mediated catabolism of protein C by pleural mesothelial and vascular endothelial cells.
Iakhiaev AV; Rezaie AR; Idell S
Thromb Haemost; 2007 Sep; 98(3):627-34. PubMed ID: 17849052
[TBL] [Abstract][Full Text] [Related]
24. Serine protease dynamics revealed by NMR analysis of the thrombin-thrombomodulin complex.
Peacock RB; McGrann T; Tonelli M; Komives EA
Sci Rep; 2021 Apr; 11(1):9354. PubMed ID: 33931701
[TBL] [Abstract][Full Text] [Related]
25. Solution structure of the smallest cofactor-active fragment of thrombomodulin.
Wood MJ; Sampoli Benitez BA; Komives EA
Nat Struct Biol; 2000 Mar; 7(3):200-4. PubMed ID: 10700277
[TBL] [Abstract][Full Text] [Related]
26. The effects of exosite occupancy on the substrate specificity of thrombin.
Ng NM; Quinsey NS; Matthews AY; Kaiserman D; Wijeyewickrema LC; Bird PI; Thompson PE; Pike RN
Arch Biochem Biophys; 2009 Sep; 489(1-2):48-54. PubMed ID: 19638274
[TBL] [Abstract][Full Text] [Related]
27. The amino terminal lectin-like domain of thrombomodulin is required for constitutive endocytosis.
Conway EM; Pollefeyt S; Collen D; Steiner-Mosonyi M
Blood; 1997 Jan; 89(2):652-61. PubMed ID: 9002969
[TBL] [Abstract][Full Text] [Related]
28. C-terminal site-specific PEGylation of a truncated thrombomodulin mutant with retention of full bioactivity.
Cazalis CS; Haller CA; Sease-Cargo L; Chaikof EL
Bioconjug Chem; 2004; 15(5):1005-9. PubMed ID: 15366953
[TBL] [Abstract][Full Text] [Related]
29. Specificity determinants of a novel Nck interaction with the juxtamembrane domain of the epidermal growth factor receptor.
Hake MJ; Choowongkomon K; Kostenko O; Carlin CR; Sönnichsen FD
Biochemistry; 2008 Mar; 47(10):3096-108. PubMed ID: 18269246
[TBL] [Abstract][Full Text] [Related]
30. Structural and functional consequences of methionine oxidation in thrombomodulin.
Wood MJ; Helena Prieto J; Komives EA
Biochim Biophys Acta; 2005 Jan; 1703(2):141-7. PubMed ID: 15680222
[TBL] [Abstract][Full Text] [Related]
31. Do-all receptor takes on coagulation, inflammation.
Esmon C
Nat Med; 2005 May; 11(5):475-7. PubMed ID: 15875050
[No Abstract] [Full Text] [Related]
32. Internalization of the anticoagulant thrombomodulin is constitutive and does not require a signal in the cytoplasmic domain.
Teasdale MS; Bird CH; Bird P
Immunol Cell Biol; 1994 Dec; 72(6):480-8. PubMed ID: 7698819
[TBL] [Abstract][Full Text] [Related]
33. The structure of a 19-residue fragment from the C-loop of the fourth epidermal growth factor-like domain of thrombomodulin.
Adler M; Seto MH; Nitecki DE; Lin JH; Light DR; Morser J
J Biol Chem; 1995 Oct; 270(40):23366-72. PubMed ID: 7559494
[TBL] [Abstract][Full Text] [Related]
34. The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism.
Abeyama K; Stern DM; Ito Y; Kawahara K; Yoshimoto Y; Tanaka M; Uchimura T; Ida N; Yamazaki Y; Yamada S; Yamamoto Y; Yamamoto H; Iino S; Taniguchi N; Maruyama I
J Clin Invest; 2005 May; 115(5):1267-74. PubMed ID: 15841214
[TBL] [Abstract][Full Text] [Related]
35. A novel C1q-domain-containing protein from Zhikong scallop Chlamys farreri with lipopolysaccharide binding activity.
Zhang H; Song L; Li C; Zhao J; Wang H; Qiu L; Ni D; Zhang Y
Fish Shellfish Immunol; 2008 Sep; 25(3):281-9. PubMed ID: 18603000
[TBL] [Abstract][Full Text] [Related]
36. NMR structure of a complex formed by the carboxyl-terminal domain of human RAP74 and a phosphorylated peptide from the central domain of the FCP1 phosphatase.
Yang A; Abbott KL; Desjardins A; Di Lello P; Omichinski JG; Legault P
Biochemistry; 2009 Mar; 48(9):1964-74. PubMed ID: 19215094
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of recombinant human soluble thrombomodulin, thrombomodulin alfa in the rat.
Tsuruta K; Kodama T; Serada M; Hori K; Inaba A; Miyake T; Kohira T
Xenobiotica; 2009 Feb; 39(2):125-34. PubMed ID: 19255938
[TBL] [Abstract][Full Text] [Related]
38. Noncompetitive inhibition of hepatocyte growth factor-dependent Met signaling by a phage-derived peptide.
Tam EM; Runyon ST; Santell L; Quan C; Yao X; Kirchhofer D; Skelton NJ; Lazarus RA
J Mol Biol; 2009 Jan; 385(1):79-90. PubMed ID: 18973760
[TBL] [Abstract][Full Text] [Related]
39. Cooperativity of the N- and C-terminal domains of insulin-like growth factor (IGF) binding protein 2 in IGF binding.
Kuang Z; Yao S; McNeil KA; Thompson JA; Bach LA; Forbes BE; Wallace JC; Norton RS
Biochemistry; 2007 Dec; 46(48):13720-32. PubMed ID: 17985932
[TBL] [Abstract][Full Text] [Related]
40. Thrombomodulin.
Weiler H; Isermann BH
J Thromb Haemost; 2003 Jul; 1(7):1515-24. PubMed ID: 12871287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
